bioMerieux (OTCMKTS:BMXMF) Shares Gap Down - Should You Sell?

bioMerieux (OTCMKTS:BMXMF - Get Free Report)'s share price gapped down before the market opened on Monday . The stock had previously closed at $142.45, but opened at $137.51. bioMerieux shares last traded at $137.51, with a volume of 4 shares traded.

Wall Street Analysts Forecast Growth

Separately, Royal Bank Of Canada cut bioMerieux from a "moderate buy" rating to a "hold" rating in a research report on Wednesday, May 7th.

bioMerieux Stock Performance

The company has a debt-to-equity ratio of 0.08, a current ratio of 2.20 and a quick ratio of 1.29. The company has a fifty day simple moving average of $138.25 and a two-hundred day simple moving average of $127.94.

About bioMerieux

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.